Cover Image
市場調查報告書

恆溫核酸增幅技術(INAAT)的全球市場-用途(感染性疾病,血液檢驗,研究),產品(計量儀器,試劑),終端用戶(醫院,參考實驗室及其他)別預測及分析

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

出版商 MarketsandMarkets 商品編碼 253613
出版日期 內容資訊 英文 215 Pages
訂單完成後即時交付
價格
Back to Top
恆溫核酸增幅技術(INAAT)的全球市場-用途(感染性疾病,血液檢驗,研究),產品(計量儀器,試劑),終端用戶(醫院,參考實驗室及其他)別預測及分析 Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
出版日期: 2014年05月16日 內容資訊: 英文 215 Pages
簡介

恆溫核酸增幅技術(INAAT)市場由於勝過傳統熱感聚合酵素鏈鎖反應(PCR)的先進等溫條件分子檢驗的需求,一般預測今後將以13.5%的年複合成長率擴大,到2018年達到16億5100萬美元的規模。

本報告以恆溫核酸增幅技術的全球市場為焦點,依用途,產品,終端用戶,地區別預測以今後到2108年前這段期間為對象的交易規模轉變,再彙整市場發展的影響要素,技術開發,競爭環境,有力企業等調查分析資訊。

第1章 簡介

  • 調查的目的
  • 報告的範圍
  • 調查方法
  • 一次·由二級資訊來源得來的重要資料

第2章 摘要整理

第3章 技術環境分析

  • 技術概要
  • 比較恆溫核酸增幅技術(INAAT)與傳統方法 - 競爭優勢
  • 技術價值鏈分析
  • 技術上的能力與成熟度
  • 檢驗結果:比較一般的核酸增幅檢查與INAAT臨床現場即時檢測
  • 各種INAAT比較分析

第4章 技術投資的未來性

  • 投資環境評估
    • 投資者網路
  • 技術評估:利害關係者間的授權·取得的可能性
  • 透過機會策略評估(OSE)電網,針對技術投資的潛力應用領域分析
    • OSE - 評估參數

第5章 市場環境分析

  • 市場區隔
  • 分子診斷法(MDX)的市場組合比例
    • 推動要素 - 說明
    • 阻礙因素 - 說明
    • 課題 - 說明
  • 需求面分析

第6章 產品市場

  • 產品·技術的改革 - 用途

第7章 用途市場

  • INAAT及分子診斷法
  • 感染性疾病診斷
  • 血液檢驗
  • 實驗室研究
  • 癌症研究
  • INAAT的全球市場 - 各用途:2013-2018年
    • 感染性疾病市場 - 各地區
    • 血液檢驗市場 - 各地區
    • 研究市場 - 各地區

第8章 最終用途市場

  • 恆溫核酸增幅技術的全球市場 - 各終端用戶:2013-2018年
  • 全球市場 - 各終端用戶
    • 醫院市場 - 各地區
    • 參考實驗室市場 - 各地區
    • 其他終端用戶市場 - 各地區
  • 醫院用INAAT市場 - 各用途
  • 參考實驗室INAAT市場 - 各用途
  • 其他針對終端用戶的INAAT市場 - 各用途

第9章 地區分析

  • 技術引進·開發 - 重要發現
    • 恆溫核酸增幅技術的全球市場 - 各地區:2013-2018年
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 高科技引進地區

第10章 競爭環境

  • 聯盟、合作,協定
  • 新產品開發
  • M&A

第11章 企業簡介

  • Alere
  • Becton, Dickinson and Company (Bd)
  • Biohelix
  • Biomerieux
  • 榮研化學株式會社
  • Hologic Gen-Probe
  • Lucigen
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • Novartis Diagnostics
  • Nugen
  • Qiagen
  • Ustar Biotechnologies (Hangzhou) Ltd.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2491

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.

Amongst different products, reagent segment is expected to grow at a faster growth due to its increasing demand in reliable, specific and faster detection of chronic diseases and genetic disorders. On the other hand, infectious disease was found to be the highest revenue generating application segment of isothermal nucleic acid amplification technology (INAAT) market in 2013; it is also expected to grow at higher CAGR of 14.4% during the forecast period due to increasing prevalence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in advanced detection of pathogens globally. Amongst different end-users, adoption of INAAT technologies in reference laboratories is expected to be significant due to increasing importance of advanced technologies in different complex molecular testing.

North America commanded the largest market share of about 44% in 2013; whereas, Asian INAAT market is expected to witness the highest CAGR. High prevalence rate of infectious diseases and significant adoption of novel technologies are the major driving factors in the Asian INAAT market. Leading players in the global INAAT market are also expected to address the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East among others.

The grey area, while estimating the market size, includes the overlapping nature of the applications. The application segment included infectious diseases, blood screening, genetics, oncology, research. It was difficult to evaluate the appropriate applications of INAAT; these were later clarified with the help of various experts that participated during the study. Technology market is not estimated as these are proprietary technologies of leading companies. However, qualitative information such as technology evolution, value chain analysis, comparative analysis of various proprietary technologies, and technology roadmap are incorporated in the research study.

The notable players in the global isothermal nucleic acid amplification technology market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).

The extensive market study covers a detailed coverage of market momentum, an in-depth analysis of various influencing factors as well as a comprehensive snapshot of competitive landscape. Such all-inclusive research would help market players to identify growth potential of different sub-segments and formulate a suitable strategy to enter various related industries with the best portfolio.

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Report Scope
  • 1.3. Research Methodology
  • 1.4. Key Data From Secondary & Primary Sources

2. Executive Summary

3. Technology Landscape Analysis

  • 3.1. Technology Overview
  • 3.2. INAAT Vs. Conventional Methods - Competitive Advantages
  • 3.3. Technology Value Chain Analysis
  • 3.4. Technology Capability and Maturity
  • 3.5. Test Results General Nat Vs. INAAT Poct
  • 3.6. Comparative Analysis Of INAAT Types

4. Technology Investment Potential

  • 4.1. Investment Climate Assessment
    • 4.1.1. Investor Network
      • 4.1.1.1. Investment Climate Assessment
      • 4.1.1.2. Philanthropic Bodies
      • 4.1.1.3. Private Investors & Venture Capital Firms
      • 4.1.1.4. Insights on Current and Future Technology Investment Trends
      • 4.1.1.5. Some Of The Funds and Investments on INAAT
  • 4.2. Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
  • 4.3. Analysis Of Potential Application Areas For Technology Investment Using Ose Grid
    • 4.3.1. Ose - Parameters For Evaluation

5. Market Landscape Analysis

  • 5.1. Market Segmentation
  • 5.2. Market Share in Molecular Diagnostics (Mdx)
  • 5.3. Market Dynamics
    • 5.3.1. Drivers - Description
    • 5.3.2. Restraints - Description
    • 5.3.3. Challenges - Description
  • 5.4. Demand-Side Analysis

6. Product Market

  • 6.1. Product/Technology Innovations - Applications
    • 6.1.1. Product/Technology Innovations - Applications
      • 6.1.1.1. INAAT Instrument Market - By Geography
      • 6.1.1.2. INAAT Reagent Market - By Geography

7. Applications Market

  • 7.1. INAAT & Molecular Diagnostics
  • 7.2. Infectious Disease Diagnostics
  • 7.3. Blood Screening
  • 7.4. Laboratory Research
  • 7.5. Cancer Research
  • 7.6. Global INAAT Market - By Application (2013-2018)
    • 7.6.1. INAAT Infectious Diseases Market, By Geography
    • 7.6.2. INAAT Blood Screening Market - By Geography
    • 7.6.3. INAAT Research Market - By Geography

8. End-User Market

  • 8.1. Global Isothermal Nucleic Acid Amplification Technology Market - By End User (2013-2018)
  • 8.2. Global Market - By End User
    • 8.2.1. INAAT Hospitals Market - By Geography
    • 8.2.2. INAAT Reference Laboratories Market - By Geography
    • 8.2.3. INAAT Other End-Users Market - By Geography
  • 8.3. INAAT Market For Hospitals, By Application
  • 8.4. INAAT Market For Reference Laboratories, By Application
  • 8.5. INAAT Market For Other End Users, By Application

9. Geographic Analysis

  • 9.1. Technology Adoption & Development - Key Findings
    • 9.1.1. Global Isothermal Nucleic Acid Amplification Technology Market - By Geography (2013-2018)
  • 9.2. North America
    • 9.2.1. North America - INAAT Market, By Application
    • 9.2.2. North America - Market, By Product
    • 9.2.3. North America - Market, By End User
  • 9.3. Europe
    • 9.3.1. Europe - INAAT Market, By Application
    • 9.3.2. Europe - Market, By Product
    • 9.3.3. Europe - Market, By End User
  • 9.4. Asia
    • 9.4.1. Asia - INAAT Market, By Application
    • 9.4.2. Asia - Market, By Product
    • 9.4.3. Asia - Market, By End User
  • 9.5. Rest Of The World (ROW)
    • 9.5.1. ROW- INAAT Market, By Application
    • 9.5.2. ROW- Market, By Product
    • 9.5.3. ROW- Market, By End User
  • 9.6. Regions With High Technology Adoption

10. Competitive Landscape

  • 10.1. Partnerships, Collaborations & Agreements
  • 10.2. New Product Launches
  • 10.3. Mergers and Acquisitions

11. Company Profiles

  • 11.1. Alere
  • 11.2. Becton, Dickinson and Company (Bd)
  • 11.3. Biohelix
  • 11.4. Biomerieux
  • 11.5. Eiken Chemical Co., Ltd.
  • 11.6. Hologic Gen-Probe
  • 11.7. Lucigen
  • 11.8. Meridian Bioscience, Inc.
  • 11.9. New England Biolabs
  • 11.10. Novartis Diagnostics
  • 11.11. Nugen
  • 11.12. Qiagen
  • 11.13. Ustar Biotechnologies (Hangzhou) Ltd.

List Of Tables

  • Table 1: NIH Funding Details and Estimation For Infectious Diseases During The Fiscal Year (Fy) 2010-2015
  • Table 2: Gates Foundation Grants ($) (2010-2014)
  • Table 3: Global Isothermal Nucleic Acid Amplification Technology Market, By Product, 2011-2018 ($Million)
  • Table 4: INAAT Instruments Market, By Geography, 2011-2018 ($Million)
  • Table 5: INAAT Reagents Market, By Geography, 2011-2018 ($Million)
  • Table 6: Global Isothermal Nucleic Acid Amplification Technology Market, By Application, 2011-2018 ($Million)
  • Table 7: INAAT Infectious Diseases Market, By Geography, 2011-2018 ($Million)
  • Table 8: INAAT Blood Screening Market, By Geography, 2011-2018 ($Million)
  • Table 9: INAAT Research Market, By Geography, 2011-2018 ($Million)
  • Table 10: Global Isothermal Nucleic Acid Amplification Technology Market, By End User, 2011-2018 ($Million)
  • Table 11: INAAT Hospitals Market, By Geography, 2011-2018 ($Million)
  • Table 12: INAAT Reference Laboratories Market, By Geography, 2011-2018 ($Million)
  • Table 13: INAAT Other End-Users Market, By Geography, 2011-2018 ($Million)
  • Table 14: INAAT Hospital Market Revenue, By Application, 2011-2018 ($Million)
  • Table 15: INAAT Reference Laboratories Market Revenue, By Application, 2011-2018 ($Million)
  • Table 16: INAAT Other End Users Market Revenue, By Application, 2011-2018 ($Million)
  • Table 17: North America: Market, By Application, 2011-2018 ($Million)
  • Table 18: North America: Market, By Product, 2011-2018 ($Million)
  • Table 19: North America: Market, By End User, 2011-2018 ($Million)
  • Table 20: Europe: Market, By Application, 2011-2018 ($Million)
  • Table 21: Europe: Market, By Product, 2011-2018 ($Million)
  • Table 22: Europe: Market, By End User, 2011-2018 ($Million)
  • Table 23: Asia: Market, By Application, 2011-2018 ($Million)
  • Table 24: Asia: Market, By Product, 2011-2018 ($Million)
  • Table 25: Asia: Market, By End User, 2011-2018 ($Million)
  • Table 26: ROW: Market, By Application, 2011-2018 ($Million)
  • Table 27: ROW: Market, By Product, 2011-2018 ($Million)
  • Table 28: ROW: Market, By End User, 2011-2018 ($Million)
  • Table 29: Partnerships, Collaborations & Agreements, 2011-2014
  • Table 30: New Product Launches, 2011-2014
  • Table 31: Mergers & Acquisitions, 2011-2014

List Of Figures

  • Figure 1: Research Methodology
  • Figure 2: INAAT Vs. Molecular Diagnostics: Market Revenue Forecast, 2011-2018
  • Figure 3: Technology Evolution
  • Figure 4: INAAT Vs. Conventional Methods - Competitive Advantages
  • Figure 5: Technology Value Chain Analysis
  • Figure 6: INAAT Capability Towards Poct
  • Figure 7: Test Results General Nat Vs. INAAT Poct
  • Figure 8: Comparative Analysis Of INAAT Types
  • Figure 9: Technology Roadmap
  • Figure 10: Attractive Forces For Increased Market Value
  • Figure 11: Investor Network
  • Figure 12: NIH Funds Towards Infectious Diseases
  • Figure 13: Opportunity Strategic Evaluation Analysis
  • Figure 14: Market Segmentation
  • Figure 15: Market Share in Molecular Diagnostics (Mdx)
  • Figure 16: Market Dynamics
  • Figure 17: Drivers Impact - Timeline
  • Figure 18: Restraints Impact - Timeline
  • Figure 19: Current and Emerging Opportunities
  • Figure 20: Demand-Side Analysis
  • Figure 21: Market Share, By Product, 2013-2018
  • Figure 22: Global Market, By Product, 2013 & 2018 ($Million)
  • Figure 23: INAAT Instruments Market, By Geography, 2013 & 2018 ($Million)
  • Figure 24: Global INAAT Reagents Market, By Geography, 2013 & 2018 ($Million)
  • Figure 25: Isothermal Nucleic Acid Amplification Technology Applications Market
  • Figure 26: INAAT Products Currently Available For Infectious Diseases
  • Figure 27: Market Share, By Application, 2013-2018
  • Figure 28: Global Market, By Application, 2013 & 2018 ($Million)
  • Figure 29: INAAT Infectious Diseases Market, By Geography, 2013 & 2018 ($Million)
  • Figure 30: INAAT Blood Screening Market, By Geography, 2013 & 2018 ($Million)
  • Figure 31: INAAT Research Market, By Geography, 2013 & 2018 ($Million)
  • Figure 32: Market Share, By End User, 2013-2018
  • Figure 33: Global Market, By End-User, 2013 & 2018 ($Million)
  • Figure 34: INAAT Hospitals Market, By Geography, 2013 & 2018 ($Million)
  • Figure 35: INAAT Reference Laboratories Market, By Geography, 2013 & 2018 ($Million)
  • Figure 36: INAAT Other End-Users Market, By Geography, 2013 & 2018 ($Million)
  • Figure 37: INAAT Hospital Market Revenue, By Application, 2013 Vs. 2018, ($Million)
  • Figure 38: INAAT Reference Laboratories Market Revenue, By Application, 2013 Vs 2018 ($Million)
  • Figure 39: INAAT Others End Users Market Revenue, By Application, 2013 Vs. 2018 ($Million)
  • Figure 40: Market Share, By Geography, 2013-2018
  • Figure 41: North America: Market, By Application, 2013 Vs. 2018 ($Million)
  • Figure 42: North America: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 43: North America: Market, By End User, 2013 Vs. 2018 ($Million)
  • Figure 44: Europe: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 45: Europe: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 46: Europe: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 47: Asia: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 48: Asia: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 49: Asia: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 50: ROW: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 51: ROW: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 52: ROW: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 53: Key Growth Strategies Of The Global Isothermal Nucleic Acid Amplification Technologies Market, 2011-2014
Back to Top